Showing results (61-70 of 74) with videos related to
Sort By:
Pageof 8
Lancet (London, England)|April 16, 2023
Efficacy and safety of ritlecitinib in adults and adolescents with alopecia areata: a randomised, double-blind, multicentre, phase 2b-3 trialBrett King, Xingqi Zhang, Walter Gubelin Harcha, et al.The Journal of Dermatology|September 27, 2024
Efficacy and safety of ritlecitinib, an oral JAK3/TEC family kinase inhibitor, in adolescent and adult patients with alopecia totalis and alopecia universalisNatasha Mesinkovska, Brett King, Xingqi Zhang, et al.The Journal of Allergy and Clinical Immunology|December 5, 2021
Ritlecitinib and brepocitinib demonstrate significant improvement in scalp alopecia areata biomarkersEmma Guttman-Yassky, Ana B Pavel, Aisleen Diaz, et al.Journal of the American Academy of Dermatology|August 12, 2015
100% Complete response rate in patients with cutaneous metastatic melanoma treated with intralesional interleukin (IL)-2, imiquimod, and topical retinoid combination therapy: results of a case seriesVivian Y Shi, Khiem Tran, Forum Patel, et al.Pharmacology Research & Perspectives|July 5, 2024
A phase 2a study investigating the effects of ritlecitinib on brainstem auditory evoked potentials and intraepidermal nerve fiber histology in adults with alopecia areataSamira Anderson, Guido Cavaletti, Linda J Hood, et al.Journal of the American Academy of Dermatology|November 12, 2022
Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trialKhaled Ezzedine, Elena Peeva, Yuji Yamaguchi, et al.Nature Communications|June 6, 2022
Inhibition of type 1 immunity with tofacitinib is associated with marked improvement in longstanding sarcoidosisWilliam Damsky, Alice Wang, Daniel J Kim, et al.Journal of the American Academy of Dermatology|April 29, 2020
The Validated Investigator Global Assessment for Atopic Dermatitis (vIGA-AD): The development and reliability testing of a novel clinical outcome measurement instrument for the severity of atopic dermatitisEric Simpson, Robert Bissonnette, Lawrence F Eichenfield, et al.Journal of the American Academy of Dermatology|March 14, 2020
The Alopecia Areata Consensus of Experts (ACE) study: Results of an international expert opinion on treatments for alopecia areataNekma Meah, Dmitri Wall, Katherine York, et al.Journal of the American Academy of Dermatology|September 14, 2020
The Alopecia Areata Consensus of Experts (ACE) study part II: Results of an international expert opinion on diagnosis and laboratory evaluation for alopecia areataNekma Meah, Dmitri Wall, Katherine York, et al.Pageof 8